Escorial, Zia .

HRN: 22-39-66  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/01/2024
AMPICILLIN 500MG (VIAL)
12/01/2024
12/08/2024
IV
520mg
Q6h
PCAP C
Waiting Final Action 
12/02/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
12/02/2024
12/09/2024
IV
4ml
TID
Amoebiasis
Waiting Final Action 
12/02/2024
CEFTRIAXONE 1G (VIAL)
12/02/2024
12/09/2024
IV
1 Gram
Q24
Amoniasis, PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: